KENNETH BROWN: Open Payments
NPI 1003435090 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 19 payments from 8 companies in 2025. Trend: 2023 $1,326 · 2024 $1,655 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $191 |
| Inspire Medical Systems, Inc. | 2 | $163 |
| GlaxoSmithKline, LLC. | 10 | $158 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Lilly USA, LLC | 1 | $121 |
| ABBVIE INC. | 1 | $119 |
| Verona Pharma, Inc. | 1 | $79 |
| CORDIS US CORP. | 1 | $19 |
Products named: INSPIRE, TRELEGY ELLIPTA, ABILIFY MAINTENA, ZEPBOUND, VRAYLAR, BREZTRI, Ohtuvayre, FASENRA.
Industry payments across NV — which companies pay providers there.
